Table 4. Plasma Lipoproteins and lipid Profile in Patients.
Variable | Baseline | 3-M Follow Up | Changes From Baseline |
---|---|---|---|
Triglycerides, mg/dL | |||
Garlic group | 85.25 ± 9.8 | 122 ± 11.8 | 35.03 ± 9.62 |
3-m follow-up | 56.24 ± 4.3 | 99.92 ± 7.9 | 42.78 ± 6.52 |
P | 0.008 | < 0.001a | 0.31a |
Cholesterol, mg/dL | |||
Garlic group | 108.1 ± 4.7 | 119.7 ± 5.0 | 11.8 ± 4.1 |
Placebo group | 110.8 ± 5.4 | 129.1 ± 10.1 | 18.1 ± 6.2 |
Pb | 0.71 | 0.41 | 0.41 |
LDL-C, mg/dL | |||
Garlic group | 54.18 ± 3.1 | 60.0 ± 3.2 | 6.1 ± 3.1 |
Placebo group | 57.5 ± 3.7 | 66.2 ± 6.07 | 8.6 ± 3.7 |
P | 0.49 | 0.38 | 0.61 |
HDL-C, mg/dL | |||
Garlic group | 33.2 ± 1.7 | 38.3 ± 1.8 | 5.1 ± 1.1 |
Placebo group | 36.1 ± 1.5 | 41.7 ± 1.8 | 5.5 ± 1.6 |
P | 0.23 | 0.19 | 0.85 |
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
aAnalysis of covariance with baseline value, as covariate, was performed.
bFor comparisons, t-test was performed.